Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 14/20 | 0.54 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.54 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.54 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | GMNN | O75496 | 1/20 | 0.49 |
| ▸ | RAPGEF3 | O95398 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.49 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.48 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16561105 | 0.92 | STING1 (0.57) | STING1PDE3BPDE3ALMNAGMNN | |
| SCHEMBL1331888 | 0.92 | STING1 (0.57) | STING1PDE3BPDE3ALMNAGMNN | |
| SCHEMBL19954155 | 0.92 | STING1 (0.57) | STING1PDE3BPDE3ALMNAGMNN | |
| SCHEMBL29359340 | 0.89 | STING1 (0.56) | STING1PDE3BPDE3ALMNAGMNN | |
| SCHEMBL1363161 | 0.89 | STING1 (0.56) | STING1PDE3BPDE3ALMNAGMNN | |
| SCHEMBL23477180 | 0.81 | STING1 (0.84) | STING1PDE3BPDE3A | |
| SCHEMBL14366370 | 0.81 | STING1 (0.84) | STING1PDE3BPDE3A | |
| SCHEMBL13687910 | 0.81 | STING1 (0.84) | STING1PDE3BPDE3A | |
| SCHEMBL13341142 | 0.81 | STING1 (0.84) | STING1PDE3BPDE3A | |
| SCHEMBL13341179 | 0.81 | STING1 (0.84) | STING1PDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024201004-A1 | COMBINATORIAL IL-15 THERAPY | Prostate Cancer Research (GB) | 2024-10-03 | — | — | WO | claimed |
| WO-2024201004-A1 | COMBINATORIAL IL-15 THERAPY | Prostate Cancer Research (GB) | 2024-10-03 | — | — | WO | disclosed |
| WO-2024076728-A1 | CYCLIC NUCLEOTIDES AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-04-11 | — | — | WO | disclosed |